FDA Drug Recalls

Recalls / Class II

Class IID-0693-2017

Product

Rabeprazole Sodium Delayed Release Tablets, 20 mg, a) 30-count bottle (NDC 65162-0724-03), b) 90-count bottle (NDC 65162-0724-09), Rx Only, Manufactured by Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad INDIA 382220, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ 08807

Affected lot / code info
Lot #: a) AR151324, AR151322, AR151325, Exp. 9/2017; AR160730A, AR160731A, AR160732A, Exp. 05/2018. b) AR151324, AR151322, AR151325, Exp. 9/2017; AR160730B, 5/2018.

Why it was recalled

Failed Dissolution Specifications

Recalling firm

Firm
Amneal Pharmaceuticals LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
118 Beaver Trl, Glasgow, Kentucky 42141-1273

Distribution

Quantity
105,215 Bottles
Distribution pattern
Nationwide within the US and PR

Timeline

Recall initiated
2016-12-12
FDA classified
2017-05-02
Posted by FDA
2017-05-10
Terminated
2019-04-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0693-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls